about
French health insurance databases: What interest for medical research?Interactions between medical residents and drug companies: a national survey after the Mediator® affairFirst French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.Risk of hormonotherapy in transgender people: Literature review and data from the French Database of Pharmacovigilance.Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies.Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®.Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry.Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment.Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients.Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study.Early signal of diverted use of tropicamide eye drops in France.Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate.Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.Benzodiazepines and risk of death: Results from two large cohort studies in France and UK.Off-label prescribing in pediatric outpatients.Analgesic Drug Prescription After Carpal Tunnel Surgery: A Pharmacoepidemiological Study Investigating Postoperative Pain.Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database.Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns--a cohort study.If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients' own stories of their experiences.Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.A novel approach for medical research on lymphomas: A study validation of claims-based algorithms to identify incident cases.Trends in opioid analgesics use in Europe: a ten-year perspectiveUn exemple d’investigation d’un phénomène « émergent » en addictovigilance : à propos du méthylphénidateAnalgesic drug consumption increases after knee arthroplasty: A pharmacoepidemiological study investigating postoperative painFirst French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic VaccinesPatterns of direct oral anticoagulant drug prescription in France in 2010-2013: a study in the Midi-Pyrénées areaCross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitusAvailability of Effective Evidence-Based Symptomatic Treatments for Cluster Headache in the EU Countries-A Survey of the European Headache Alliance and European Headache Federation
P50
Q26995060-81E47595-415A-46A8-A199-F418F6292EC7Q28543522-7F9AA5B2-D261-43DA-80B0-47D54319922CQ30421150-80A143DE-BAFB-4A50-8A0E-B4A7D573C664Q31041835-F0F3CEFC-F5B2-4CF1-8F6A-665B2017AA34Q31111099-3635F7BA-A150-4713-84A4-EB318776916AQ33418132-E90E0A78-0985-4875-8118-42B2736A6558Q33425628-04D889BE-46B1-4D56-B1BB-A3F1963C2AF9Q33427488-F0FFEE3C-0BB5-4048-A9DC-7CEA5CFD433EQ33438334-C75D94D8-906F-4F67-9FFB-8C1BBE65371CQ36318112-713C9FB5-9B4D-4964-A327-B6E3A7C091F5Q38440511-D3A388CB-3FCC-481F-94D1-153A30B270AEQ38660850-63E1E864-14CD-4CF6-9515-7B685DCE9F3EQ38685426-E9C51C9F-FF06-437C-911B-E4305AA4FBF0Q38940500-1B8D4AE4-8F20-4626-A752-4639D685DE8EQ41095304-2AAE9C22-7EC1-411E-A558-62FBB7AC28CEQ41500733-BF989DB8-D676-4A05-B2FF-08A05309988DQ41500742-E2B835B7-A476-45F6-870B-135A9CB0DEE0Q41686093-2AAF78A8-C8D1-4DD6-9936-808E2BBE0E65Q47591136-EC50F949-2983-49A9-B87A-74920D616693Q48156007-E418ABA4-6ECF-47B8-8D2E-2066AAF56ACFQ48235838-BFB9879E-80C4-4950-8FDF-550F0696974BQ51227735-A31BFFE6-43A5-4FCA-B652-E36A310BDE24Q52596931-FDEAD98C-6552-47C7-856B-08168DAD291BQ52657412-8B70C9F1-6B80-4D59-B9EF-6002D0002925Q52685422-DBFF3C85-4E61-448B-A5DC-D64F4A643988Q57837281-DBB4EE11-5A04-49A5-8DCC-EE5D658601B1Q57837287-DB24FB9E-D426-4D74-A535-D2B566541C3FQ57837306-D0704520-243A-4147-B962-0CFA14123A5DQ60619175-599EC181-33E4-43DD-ACEC-A4715C0B671FQ88197018-E0726FAC-30B4-4E71-846E-7886B88CEB7EQ90906709-A0F9C4C8-71C2-476E-B056-EA69CF328AE1Q92147093-1A4F7249-98DF-497B-A220-778E9F2C356B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Aurore Palmaro
@ast
Aurore Palmaro
@en
Aurore Palmaro
@es
Aurore Palmaro
@nl
Aurore Palmaro
@sl
type
label
Aurore Palmaro
@ast
Aurore Palmaro
@en
Aurore Palmaro
@es
Aurore Palmaro
@nl
Aurore Palmaro
@sl
prefLabel
Aurore Palmaro
@ast
Aurore Palmaro
@en
Aurore Palmaro
@es
Aurore Palmaro
@nl
Aurore Palmaro
@sl
P1053
N-3112-2015
P106
P1153
55355597000
P31
P3829
P496
0000-0002-5660-9224